Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

CALGB 30103: A randomized phase II study of carboplatin and etoposide (CE) with or without G3139 in patients with extensive stage small cell lung cancer (ES-SCLC).

Rudin CM, Salgia R, Wang XF, Green MR, Vokes EE. CALGB 30103: A randomized phase II study of carboplatin and etoposide (CE) with or without G3139 in patients with extensive stage small cell lung cancer (ES-SCLC). J Clin Oncol. 2005 Jun; 23(16_suppl):7168.

View in: PubMed

collapse authors with profiles